Recent Posts

Podcast: Insight One – What are degraders?

Podcast: Insight One – What are degraders?

In this podcast Oskar Hoff, Head of Medicinal Chemistry, talks to Amir Amanzadi, Head of Comp. Chemistry, about degraders in general, and how they work compared to inhibitors. Insight One The beginning of Celeris Therapeutics What role does AI play? What are degraders? Why degraders, and what’s the impact? How does a job as Machine […]

Read more

The Third Wave of Degrader Discovery

The Third Wave of Degrader Discovery

The Third Wave of Degrader Discovery Proteins occupy a special place in the biological domain as the master regulators of biochemical processes in the cell. They accomplish this as enzymes, hormones, transporters, signal transducers, and other complex molecules to ensure the cell maintains a homeostatic balance. This system, while amazingly resilient, breaks down when those […]

Read more

Podcast: Insight One – What role does AI play?

Podcast: Insight One – What role does AI play?

In this podcast Oskar Hoff, Head of Medicinal Chemistry, talks to Hosein Fooladi, CSO, and Noah Weber, CTO, about state of the art AI technologies and how it connects to Celeris Therapeutics and what they foresee for the next ten years. Insight One The beginning of Celeris Therapeutics What role does AI play? What are […]

Read more

Webinar: Machine Learning meets Degrader Design

Webinar: Machine Learning meets Degrader Design
Read more

Longevity and AI v2.0

Longevity and AI v2.0

With the new book The Science and Technology of Growing Young by Sergey Young, we, Celeris Therapeutics, an AI company in this space, had to analyze the book through our AI lense and pose potential approaches to tackle the problems outlined in the book. “Aging, quite simply, is a loss of information”, Dr. David Sinclair If one peels […]

Read more

Podcast: Insight One – The beginning of Celeris Therapeutics

Podcast: Insight One – The beginning of Celeris Therapeutics

In this podcast Amir Amanzadi, Head of Computational Chemistry, talks to Christopher Trummer, CEO and Co-Founder, and Jakob Hohenberger, COO/CFO and Co-Founder, about the beginning of Celeris Therapeutics. Insight One The beginning of Celeris Therapeutics (this episode) What role does AI play? What are degraders? Why degraders, and what’s the impact? How does a job […]

Read more

8

Load more